EXTENDING LIFE AFTER LUNG TRANSPLANTATION - DEFINING THE STRUCTURAL AND IMMUNOLOGICAL DRIVERS OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION
Grant number: 1144826 | Funding period: 2018 - 2020
Lung Transplantation (LTx) saves life. However, chronic rejection limits survival after LTx compared to other solid organ transplants. Chronic rejection develops when the LTx recipient produces antibodies against the donor lung. With a team of global leaders in the field we will dissect the antibody response to LTx. By better understanding the immune drivers of antibody-mediated rejection, we aim to reduce the incidence of chronic rejection thereby improving survival after LTx.